LRG induces autophagy through the AMPK/mTOR/Beclin1 pathway, regulating the expression of autophagy proteins SQSTM1/P62 and LC3B, thereby improving hepatic lipid accumulation in NAFLD. Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.